Celsius (NASDAQ:CELH – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Roth Mkm in a research report issued on Friday,Benzinga reports. They presently have a $38.00 price objective on the stock. Roth Mkm’s price target points to a potential upside of 14.64% from the company’s current price.
CELH has been the topic of a number of other reports. Piper Sandler cut their price objective on Celsius from $47.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, January 23rd. Jefferies Financial Group decreased their price objective on shares of Celsius from $44.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, December 19th. B. Riley restated a “buy” rating and issued a $49.00 target price (up previously from $44.00) on shares of Celsius in a report on Friday. Needham & Company LLC restated a “buy” rating and issued a $38.00 target price on shares of Celsius in a research note on Tuesday, January 28th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Celsius in a report on Thursday, December 12th. They issued an “overweight” rating and a $37.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Celsius presently has an average rating of “Moderate Buy” and an average target price of $47.67.
Read Our Latest Stock Report on Celsius
Celsius Stock Performance
Celsius (NASDAQ:CELH – Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. The business had revenue of $332.20 million for the quarter, compared to the consensus estimate of $326.07 million. Celsius had a net margin of 15.61% and a return on equity of 59.40%. On average, research analysts forecast that Celsius will post 0.67 earnings per share for the current year.
Insider Buying and Selling at Celsius
In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the sale, the insider now owns 261,245 shares of the company’s stock, valued at approximately $8,137,781.75. This trade represents a 19.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.20% of the stock is currently owned by corporate insiders.
Institutional Trading of Celsius
Hedge funds and other institutional investors have recently made changes to their positions in the stock. HM Payson & Co. raised its stake in shares of Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock valued at $26,000 after purchasing an additional 550 shares in the last quarter. Signaturefd LLC boosted its holdings in Celsius by 48.3% during the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after buying an additional 378 shares in the last quarter. Activest Wealth Management acquired a new stake in shares of Celsius during the third quarter worth $39,000. Blue Trust Inc. raised its stake in Celsius by 69.0% during the 3rd quarter. Blue Trust Inc. now owns 1,345 shares of the company’s stock valued at $42,000 after purchasing an additional 549 shares during the period. Finally, S.A. Mason LLC grew its stake in Celsius by 100.0% in the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock valued at $37,000 after buying an additional 700 shares during the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- Investing in the High PE Growth Stocks
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Stock Market Upgrades: What Are They?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Do ETFs Pay Dividends? What You Need to Know
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.